Compare CTM & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTM | HYFT |
|---|---|---|
| Founded | 2019 | 1983 |
| Country | United States | United States |
| Employees | N/A | 102 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.1M | 66.8M |
| IPO Year | 2022 | N/A |
| Metric | CTM | HYFT |
|---|---|---|
| Price | $0.66 | $1.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 2.1M | 254.1K |
| Earning Date | 05-08-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.33 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $52,866,001.00 | N/A |
| Revenue This Year | $20.36 | N/A |
| Revenue Next Year | $6.37 | $29.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 18.10 | N/A |
| 52 Week Low | $0.48 | $0.99 |
| 52 Week High | $1.36 | $3.00 |
| Indicator | CTM | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 48.33 |
| Support Level | $0.64 | $1.39 |
| Resistance Level | $0.76 | $1.96 |
| Average True Range (ATR) | 0.03 | 0.10 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 37.35 | 36.17 |
Castellum Inc is focused on building a successful technology services, solutions, and products company in the areas of cybersecurity, IT, electronic warfare, information warfare, system modernization, and information operations with businesses in the defense, federal, civilian, and commercial markets. Services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model-based systems engineering. The company maintains one operating and reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.